CJC-1295 (No DAC) / Ipamorelin Combo
(Dual Peptide Growth Hormone Secretagogue Stack)
The CJC-1295 (No DAC) / Ipamorelin combination is a research-driven peptide stack designed to support physiologic growth hormone release through two complementary pathways. It is widely studied for its applications in regeneration, hormonal signaling, and recovery. Areas of interest include:
-
Optimized GH Pulsatility
This combo is being evaluated for its ability to mimic the body’s natural growth hormone rhythm through coordinated pituitary signaling. -
Tissue Repair and Recovery
Researchers are exploring its role in accelerating muscle recovery, connective tissue regeneration, and post-exertional repair. -
Age-Related Hormonal Decline
The combination is under investigation for its impact on restoring youthful GH patterns without overstimulating other endocrine systems.
How It Works
CJC-1295 (No DAC) is a short-acting GHRH analog that stimulates the release of growth hormone by binding to GHRH receptors on the anterior pituitary. Ipamorelin is a selective ghrelin receptor agonist (GHSR-1a) that enhances this effect by amplifying GH release through a different receptor system. Unlike older GH secretagogues, Ipamorelin does not significantly affect cortisol or prolactin. When used together, these peptides provide a dual-signal stimulus to the pituitary, supporting a more natural, pulse-like GH release pattern—ideal for regenerative and recovery-focused research.
⚠️ Important Notice:
This product is sold strictly for laboratory research purposes only. It is not for human or animal use, and not for therapeutic or diagnostic applications.
By purchasing, you confirm that you are a qualified individual using this product in accordance with all applicable laws and research regulations.
